TENON MEDICAL INC (TNON) Fundamental Analysis & Valuation

NASDAQ:TNON • US88066N3035

Current stock price

0.8017 USD
-0.02 (-2.06%)
At close:
0.8001 USD
0 (-0.2%)
After Hours:

This TNON fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. TNON Profitability Analysis

1.1 Basic Checks

  • In the past year TNON has reported negative net income.
  • In the past year TNON has reported a negative cash flow from operations.
  • In the past 5 years TNON always reported negative net income.
  • TNON had a negative operating cash flow in each of the past 5 years.
TNON Yearly Net Income VS EBIT VS OCF VS FCFTNON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

  • TNON's Return On Assets of -123.59% is on the low side compared to the rest of the industry. TNON is outperformed by 84.57% of its industry peers.
  • TNON's Return On Equity of -267.01% is on the low side compared to the rest of the industry. TNON is outperformed by 80.32% of its industry peers.
Industry RankSector Rank
ROA -123.59%
ROE -267.01%
ROIC N/A
ROA(3y)-185.03%
ROA(5y)-156.48%
ROE(3y)-844.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TNON Yearly ROA, ROE, ROICTNON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

  • TNON has a Gross Margin (52.40%) which is comparable to the rest of the industry.
  • TNON's Gross Margin has declined in the last couple of years.
  • TNON does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.76%
GM growth 5Y-8.18%
TNON Yearly Profit, Operating, Gross MarginsTNON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. TNON Health Analysis

2.1 Basic Checks

  • TNON does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • TNON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TNON Yearly Shares OutstandingTNON Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
TNON Yearly Total Debt VS Total AssetsTNON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • Based on the Altman-Z score of -13.05, we must say that TNON is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -13.05, TNON is doing worse than 84.57% of the companies in the same industry.
  • TNON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -13.05
ROIC/WACCN/A
WACC8.66%
TNON Yearly LT Debt VS Equity VS FCFTNON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

2.3 Liquidity

  • TNON has a Current Ratio of 2.15. This indicates that TNON is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.15, TNON is in line with its industry, outperforming 40.96% of the companies in the same industry.
  • A Quick Ratio of 1.70 indicates that TNON should not have too much problems paying its short term obligations.
  • The Quick ratio of TNON (1.70) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.15
Quick Ratio 1.7
TNON Yearly Current Assets VS Current LiabilitesTNON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. TNON Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 91.16% over the past year.
EPS 1Y (TTM)91.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.04%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%92.34%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.68% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 64.06% on average over the next years. This is a very strong growth
EPS Next Y58.25%
EPS Next 2Y30.52%
EPS Next 3Y22.93%
EPS Next 5Y15.68%
Revenue Next Year67.05%
Revenue Next 2Y58.58%
Revenue Next 3Y75.12%
Revenue Next 5Y64.06%

3.3 Evolution

TNON Yearly Revenue VS EstimatesTNON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10M 20M 30M 40M
TNON Yearly EPS VS EstimatesTNON Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -50 -100 -150

More info and screens

Find the best growth stocksShow best growing peers

1

4. TNON Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for TNON. In the last year negative earnings were reported.
  • Also next year TNON is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TNON Price Earnings VS Forward Price EarningsTNON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TNON Per share dataTNON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as TNON's earnings are expected to grow with 22.93% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.52%
EPS Next 3Y22.93%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TNON Dividend Analysis

5.1 Amount

  • No dividends for TNON!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TNON Fundamentals: All Metrics, Ratios and Statistics

TENON MEDICAL INC

NASDAQ:TNON (4/17/2026, 8:00:02 PM)

After market: 0.8001 0 (-0.2%)

0.8017

-0.02 (-2.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-19
Earnings (Next)05-11
Inst Owners3.82%
Inst Owner Change0%
Ins Owners7.07%
Ins Owner Change12.05%
Market Cap9.06M
Revenue(TTM)N/A
Net Income(TTM)-12.81M
Analysts82.5
Price Target2.81 (250.51%)
Short Float %2.59%
Short Ratio0.2
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.46%
Min EPS beat(2)-5.99%
Max EPS beat(2)24.91%
EPS beat(4)3
Avg EPS beat(4)7.92%
Min EPS beat(4)-5.99%
Max EPS beat(4)24.91%
EPS beat(8)7
Avg EPS beat(8)14.46%
EPS beat(12)10
Avg EPS beat(12)13.96%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-18.33%
Min Revenue beat(2)-39.2%
Max Revenue beat(2)2.53%
Revenue beat(4)1
Avg Revenue beat(4)-31.32%
Min Revenue beat(4)-47.97%
Max Revenue beat(4)2.53%
Revenue beat(8)1
Avg Revenue beat(8)-23.82%
Revenue beat(12)1
Avg Revenue beat(12)-19.96%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.8
P/FCF N/A
P/OCF N/A
P/B 1.89
P/tB 4.79
EV/EBITDA N/A
EPS(TTM)-2.15
EYN/A
EPS(NY)-0.9
Fwd EYN/A
FCF(TTM)-1
FCFYN/A
OCF(TTM)-1
OCFYN/A
SpS0.29
BVpS0.42
TBVpS0.17
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -123.59%
ROE -267.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.4%
FCFM N/A
ROA(3y)-185.03%
ROA(5y)-156.48%
ROE(3y)-844.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.76%
GM growth 5Y-8.18%
F-Score3
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16.49%
Cap/Sales 1.45%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.15
Quick Ratio 1.7
Altman-Z -13.05
F-Score3
WACC8.66%
ROIC/WACCN/A
Cap/Depr(3y)429.83%
Cap/Depr(5y)N/A
Cap/Sales(3y)47.06%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)91.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.04%
EPS Next Y58.25%
EPS Next 2Y30.52%
EPS Next 3Y22.93%
EPS Next 5Y15.68%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%92.34%
Revenue Next Year67.05%
Revenue Next 2Y58.58%
Revenue Next 3Y75.12%
Revenue Next 5Y64.06%
EBIT growth 1Y4.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y19.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.01%
OCF growth 3YN/A
OCF growth 5YN/A

TENON MEDICAL INC / TNON Fundamental Analysis FAQ

What is the fundamental rating for TNON stock?

ChartMill assigns a fundamental rating of 2 / 10 to TNON.


Can you provide the valuation status for TENON MEDICAL INC?

ChartMill assigns a valuation rating of 1 / 10 to TENON MEDICAL INC (TNON). This can be considered as Overvalued.


What is the profitability of TNON stock?

TENON MEDICAL INC (TNON) has a profitability rating of 0 / 10.


What is the earnings growth outlook for TENON MEDICAL INC?

The Earnings per Share (EPS) of TENON MEDICAL INC (TNON) is expected to grow by 58.25% in the next year.